-
1
-
-
84966309581
-
CANCER IMMUNOLOGY. The “cancer immunogram”
-
Blank, C.U., Haanen, J.B., Ribas, A., Schumacher, T.N., CANCER IMMUNOLOGY. The “cancer immunogram”. Science 352 (2016), 658–660.
-
(2016)
Science
, vol.352
, pp. 658-660
-
-
Blank, C.U.1
Haanen, J.B.2
Ribas, A.3
Schumacher, T.N.4
-
2
-
-
84944937210
-
Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
-
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D.R., Steins, M., Ready, N.E., Chow, L.Q., Vokes, E.E., Felip, E., Holgado, E., et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N. Engl. J. Med. 373 (2015), 1627–1639.
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 1627-1639
-
-
Borghaei, H.1
Paz-Ares, L.2
Horn, L.3
Spigel, D.R.4
Steins, M.5
Ready, N.E.6
Chow, L.Q.7
Vokes, E.E.8
Felip, E.9
Holgado, E.10
-
3
-
-
84863922124
-
Comprehensive molecular characterization of human colon and rectal cancer
-
Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 (2012), 330–337.
-
(2012)
Nature
, vol.487
, pp. 330-337
-
-
-
4
-
-
84862506964
-
A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3
-
Cingolani, P., Platts, A., Wang, L., Coon, M., Nguyen, T., Wang, L., Land, S.J., Lu, X., Ruden, D.M., A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6 (2012), 80–92.
-
(2012)
Fly (Austin)
, vol.6
, pp. 80-92
-
-
Cingolani, P.1
Platts, A.2
Wang, L.3
Coon, M.4
Nguyen, T.5
Wang, L.6
Land, S.J.7
Lu, X.8
Ruden, D.M.9
-
5
-
-
33846414709
-
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features
-
Dangles-Marie, V., Pocard, M., Richon, S., Weiswald, L.B., Assayag, F., Saulnier, P., Judde, J.G., Janneau, J.L., Auger, N., Validire, P., et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res. 67 (2007), 398–407.
-
(2007)
Cancer Res.
, vol.67
, pp. 398-407
-
-
Dangles-Marie, V.1
Pocard, M.2
Richon, S.3
Weiswald, L.B.4
Assayag, F.5
Saulnier, P.6
Judde, J.G.7
Janneau, J.L.8
Auger, N.9
Validire, P.10
-
6
-
-
33847787987
-
HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression
-
Dierssen, J.W., de Miranda, N.F., Ferrone, S., van Puijenbroek, M., Cornelisse, C.J., Fleuren, G.J., van Wezel, T., Morreau, H., HNPCC versus sporadic microsatellite-unstable colon cancers follow different routes toward loss of HLA class I expression. BMC Cancer 7 (2007), 33–43.
-
(2007)
BMC Cancer
, vol.7
, pp. 33-43
-
-
Dierssen, J.W.1
de Miranda, N.F.2
Ferrone, S.3
van Puijenbroek, M.4
Cornelisse, C.J.5
Fleuren, G.J.6
van Wezel, T.7
Morreau, H.8
-
7
-
-
85013040069
-
Genomics- and transcriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a review
-
Dijkstra, K.K., Voabil, P., Schumacher, T.N., Voest, E.E., Genomics- and transcriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a review. JAMA Oncol. 2 (2016), 1490–1495.
-
(2016)
JAMA Oncol.
, vol.2
, pp. 1490-1495
-
-
Dijkstra, K.K.1
Voabil, P.2
Schumacher, T.N.3
Voest, E.E.4
-
8
-
-
0037829421
-
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients
-
Dudley, M.E., Wunderlich, J.R., Shelton, T.E., Even, J., Rosenberg, S.A., Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J. Immunother. 26 (2003), 332–342.
-
(2003)
J. Immunother.
, vol.26
, pp. 332-342
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Shelton, T.E.3
Even, J.4
Rosenberg, S.A.5
-
9
-
-
84929481480
-
Pembrolizumab for the treatment of non-small-cell lung cancer
-
Garon, E.B., Rizvi, N.A., Hui, R., Leighl, N., Balmanoukian, A.S., Eder, J.P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al., KEYNOTE-001 Investigators. Pembrolizumab for the treatment of non-small-cell lung cancer. N. Engl. J. Med. 372 (2015), 2018–2028.
-
(2015)
N. Engl. J. Med.
, vol.372
, pp. 2018-2028
-
-
Garon, E.B.1
Rizvi, N.A.2
Hui, R.3
Leighl, N.4
Balmanoukian, A.S.5
Eder, J.P.6
Patnaik, A.7
Aggarwal, C.8
Gubens, M.9
Horn, L.10
-
10
-
-
85016162669
-
Designer matrices for intestinal stem cell and organoid culture
-
Gjorevski, N., Sachs, N., Manfrin, A., Giger, S., Bragina, M.E., Ordóñez-Morán, P., Clevers, H., Lutolf, M.P., Designer matrices for intestinal stem cell and organoid culture. Nature 539 (2016), 560–564.
-
(2016)
Nature
, vol.539
, pp. 560-564
-
-
Gjorevski, N.1
Sachs, N.2
Manfrin, A.3
Giger, S.4
Bragina, M.E.5
Ordóñez-Morán, P.6
Clevers, H.7
Lutolf, M.P.8
-
11
-
-
84866434919
-
Genomic landscape of non-small cell lung cancer in smokers and never-smokers
-
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N.D., Kanchi, K.L., Maher, C.A., Fulton, R., Fulton, L., Wallis, J., et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 150 (2012), 1121–1134.
-
(2012)
Cell
, vol.150
, pp. 1121-1134
-
-
Govindan, R.1
Ding, L.2
Griffith, M.3
Subramanian, J.4
Dees, N.D.5
Kanchi, K.L.6
Maher, C.A.7
Fulton, R.8
Fulton, L.9
Wallis, J.10
-
12
-
-
84959152038
-
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
-
Gros, A., Parkhurst, M.R., Tran, E., Pasetto, A., Robbins, P.F., Ilyas, S., Prickett, T.D., Gartner, J.J., Crystal, J.S., Roberts, I.M., et al. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients. Nat. Med. 22 (2016), 433–438.
-
(2016)
Nat. Med.
, vol.22
, pp. 433-438
-
-
Gros, A.1
Parkhurst, M.R.2
Tran, E.3
Pasetto, A.4
Robbins, P.F.5
Ilyas, S.6
Prickett, T.D.7
Gartner, J.J.8
Crystal, J.S.9
Roberts, I.M.10
-
13
-
-
84994235704
-
Screening out irrelevant cell-based models of disease
-
Horvath, P., Aulner, N., Bickle, M., Davies, A.M., Nery, E.D., Ebner, D., Montoya, M.C., Östling, P., Pietiäinen, V., Price, L.S., et al. Screening out irrelevant cell-based models of disease. Nat. Rev. Drug Discov. 15 (2016), 751–769.
-
(2016)
Nat. Rev. Drug Discov.
, vol.15
, pp. 751-769
-
-
Horvath, P.1
Aulner, N.2
Bickle, M.3
Davies, A.M.4
Nery, E.D.5
Ebner, D.6
Montoya, M.C.7
Östling, P.8
Pietiäinen, V.9
Price, L.S.10
-
14
-
-
84936147067
-
Combined nivolumab and ipilimumab or monotherapy in untreated melanoma
-
Larkin, J., Chiarion-Sileni, V., Gonzalez, R., Grob, J.J., Cowey, C.L., Lao, C.D., Schadendorf, D., Dummer, R., Smylie, M., Rutkowski, P., et al. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373 (2015), 23–34.
-
(2015)
N. Engl. J. Med.
, vol.373
, pp. 23-34
-
-
Larkin, J.1
Chiarion-Sileni, V.2
Gonzalez, R.3
Grob, J.J.4
Cowey, C.L.5
Lao, C.D.6
Schadendorf, D.7
Dummer, R.8
Smylie, M.9
Rutkowski, P.10
-
15
-
-
84856565531
-
SomaticSniper: identification of somatic point mutations in whole genome sequencing data
-
Larson, D.E., Harris, C.C., Chen, K., Koboldt, D.C., Abbott, T.E., Dooling, D.J., Ley, T.J., Mardis, E.R., Wilson, R.K., Ding, L., SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28 (2012), 311–317.
-
(2012)
Bioinformatics
, vol.28
, pp. 311-317
-
-
Larson, D.E.1
Harris, C.C.2
Chen, K.3
Koboldt, D.C.4
Abbott, T.E.5
Dooling, D.J.6
Ley, T.J.7
Mardis, E.R.8
Wilson, R.K.9
Ding, L.10
-
16
-
-
84932628341
-
PD-1 blockade in tumors with mismatch-repair deficiency
-
Le, D.T., Uram, J.N., Wang, H., Bartlett, B.R., Kemberling, H., Eyring, A.D., Skora, A.D., Luber, B.S., Azad, N.S., Laheru, D., et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372 (2015), 2509–2520.
-
(2015)
N. Engl. J. Med.
, vol.372
, pp. 2509-2520
-
-
Le, D.T.1
Uram, J.N.2
Wang, H.3
Bartlett, B.R.4
Kemberling, H.5
Eyring, A.D.6
Skora, A.D.7
Luber, B.S.8
Azad, N.S.9
Laheru, D.10
-
17
-
-
85026265866
-
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
-
Le, D.T., Durham, J.N., Smith, K.N., Wang, H., Bartlett, B.R., Aulakh, L.K., Lu, S., Kemberling, H., Wilt, C., Luber, B.S., et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357 (2017), 409–413.
-
(2017)
Science
, vol.357
, pp. 409-413
-
-
Le, D.T.1
Durham, J.N.2
Smith, K.N.3
Wang, H.4
Bartlett, B.R.5
Aulakh, L.K.6
Lu, S.7
Kemberling, H.8
Wilt, C.9
Luber, B.S.10
-
18
-
-
84923869699
-
Human biosample authentication using the high-throughput, cost-effective SNPtrace(™) system
-
Liang-Chu, M.M.Y., Yu, M., Haverty, P.M., Koeman, J., Ziegle, J., Lee, M., Bourgon, R., Neve, R.M., Human biosample authentication using the high-throughput, cost-effective SNPtrace(™) system. PLoS ONE, 10, 2015, e0116218.
-
(2015)
PLoS ONE
, vol.10
, pp. e0116218
-
-
Liang-Chu, M.M.Y.1
Yu, M.2
Haverty, P.M.3
Koeman, J.4
Ziegle, J.5
Lee, M.6
Bourgon, R.7
Neve, R.M.8
-
19
-
-
77956295988
-
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data
-
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., DePristo, M.A., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20 (2010), 1297–1303.
-
(2010)
Genome Res.
, vol.20
, pp. 1297-1303
-
-
McKenna, A.1
Hanna, M.2
Banks, E.3
Sivachenko, A.4
Cibulskis, K.5
Kernytsky, A.6
Garimella, K.7
Altshuler, D.8
Gabriel, S.9
Daly, M.10
DePristo, M.A.11
-
20
-
-
85025439295
-
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
-
Overman, M.J., McDermott, R., Leach, J.L., Lonardi, S., Lenz, H.J., Morse, M.A., Desai, J., Hill, A., Axelson, M., Moss, R.A., et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 18 (2017), 1182–1191.
-
(2017)
Lancet Oncol.
, vol.18
, pp. 1182-1191
-
-
Overman, M.J.1
McDermott, R.2
Leach, J.L.3
Lonardi, S.4
Lenz, H.J.5
Morse, M.A.6
Desai, J.7
Hill, A.8
Axelson, M.9
Moss, R.A.10
-
21
-
-
85043396361
-
Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer
-
Overman, M.J., Lonardi, S., Wong, K.Y.M., Lenz, H.J., Gelsomino, F., Aglietta, M., Morse, M.A., Van Cutsem, E., McDermott, R., Hill, A., et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer. J. Clin. Oncol. 36 (2018), 773–779.
-
(2018)
J. Clin. Oncol.
, vol.36
, pp. 773-779
-
-
Overman, M.J.1
Lonardi, S.2
Wong, K.Y.M.3
Lenz, H.J.4
Gelsomino, F.5
Aglietta, M.6
Morse, M.A.7
Van Cutsem, E.8
McDermott, R.9
Hill, A.10
-
22
-
-
85043766913
-
Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies
-
Patel, S.A., Minn, A.J., Combination cancer therapy with immune checkpoint blockade: mechanisms and strategies. Immunity 48 (2018), 417–433.
-
(2018)
Immunity
, vol.48
, pp. 417-433
-
-
Patel, S.A.1
Minn, A.J.2
-
23
-
-
84975059616
-
Resistance mechanisms to immune checkpoint blockade in cancer: tumor-intrinsic and –extrinsic factors
-
Pitt, J.M., Vétizou, M., Daillère, R., Roberti, M.P., Yamazaki, T., Routy, B., Lepage, P., Boneca, I.G., Chamaillard, M., Kroemer, G., Zitvogel, L., Resistance mechanisms to immune checkpoint blockade in cancer: tumor-intrinsic and –extrinsic factors. Immunity 44 (2016), 1255–1269.
-
(2016)
Immunity
, vol.44
, pp. 1255-1269
-
-
Pitt, J.M.1
Vétizou, M.2
Daillère, R.3
Roberti, M.P.4
Yamazaki, T.5
Routy, B.6
Lepage, P.7
Boneca, I.G.8
Chamaillard, M.9
Kroemer, G.10
Zitvogel, L.11
-
24
-
-
84928759208
-
Adoptive cell transfer as personalized immunotherapy for human cancer
-
Rosenberg, S.A., Restifo, N.P., Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348 (2015), 62–68.
-
(2015)
Science
, vol.348
, pp. 62-68
-
-
Rosenberg, S.A.1
Restifo, N.P.2
-
25
-
-
85049020799
-
Long-term expanding human airway organoids for disease modeling
-
Sachs, N., Zomer-van Ommen, D.D., Papaspyropoulos, A., Heo, I., Bottinger, L., Klay, D., Weeber, F., Huelsz-Prince, G., Lakobachvili, N., Viveen, M.C., et al. Long-term expanding human airway organoids for disease modeling. bioRxiv, 2018, 10.1101/318444.
-
(2018)
bioRxiv
-
-
Sachs, N.1
Zomer-van Ommen, D.D.2
Papaspyropoulos, A.3
Heo, I.4
Bottinger, L.5
Klay, D.6
Weeber, F.7
Huelsz-Prince, G.8
Lakobachvili, N.9
Viveen, M.C.10
-
26
-
-
84863205849
-
NIH Image to ImageJ: 25 years of image analysis
-
Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9 (2012), 671–675.
-
(2012)
Nat. Methods
, vol.9
, pp. 671-675
-
-
Schneider, C.A.1
Rasband, W.S.2
Eliceiri, K.W.3
-
27
-
-
85012225053
-
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors
-
Schütte, M., Risch, T., Abdavi-Azar, N., Boehnke, K., Schumacher, D., Keil, M., Yildiriman, R., Jandrasits, C., Borodina, T., Amstislavskiv, V., et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat. Commun., 8, 2017, 14262.
-
(2017)
Nat. Commun.
, vol.8
, pp. 14262
-
-
Schütte, M.1
Risch, T.2
Abdavi-Azar, N.3
Boehnke, K.4
Schumacher, D.5
Keil, M.6
Yildiriman, R.7
Jandrasits, C.8
Borodina, T.9
Amstislavskiv, V.10
-
28
-
-
85012158583
-
Primary, adaptive, and acquired resistance to cancer immunotherapy
-
Sharma, P., Hu-Lieskovan, S., Wargo, J.A., Ribas, A., Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168 (2017), 707–723.
-
(2017)
Cell
, vol.168
, pp. 707-723
-
-
Sharma, P.1
Hu-Lieskovan, S.2
Wargo, J.A.3
Ribas, A.4
-
29
-
-
84933508708
-
Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells
-
Stevanović S., Draper, L.M., Langhan, M.M., Campbell, T.E., Kwong, M.L., Wunderlich, J.R., Dudley, M.E., Yang, J.C., Sherry, R.M., Kammula, U.S., et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells. J. Clin. Oncol. 33 (2015), 1543–1550.
-
(2015)
J. Clin. Oncol.
, vol.33
, pp. 1543-1550
-
-
Stevanović, S.1
Draper, L.M.2
Langhan, M.M.3
Campbell, T.E.4
Kwong, M.L.5
Wunderlich, J.R.6
Dudley, M.E.7
Yang, J.C.8
Sherry, R.M.9
Kammula, U.S.10
-
30
-
-
84925550130
-
OptiType: precision HLA typing from next-generation sequencing data
-
Szolek, A., Schubert, B., Mohr, C., Sturm, M., Feldhahn, M., Kohlbacher, O., OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics 30 (2014), 3310–3316.
-
(2014)
Bioinformatics
, vol.30
, pp. 3310-3316
-
-
Szolek, A.1
Schubert, B.2
Mohr, C.3
Sturm, M.4
Feldhahn, M.5
Kohlbacher, O.6
-
31
-
-
0000861540
-
Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24
-
Tanabe, H., Takada, Y., Minegishi, D., Kurematsu, M., Masui, T., Mizusawa, H., Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24. Tiss. Cult. Res. Commun. 18 (1999), 329–338.
-
(1999)
Tiss. Cult. Res. Commun.
, vol.18
, pp. 329-338
-
-
Tanabe, H.1
Takada, Y.2
Minegishi, D.3
Kurematsu, M.4
Masui, T.5
Mizusawa, H.6
-
32
-
-
84928974420
-
Prospective derivation of a living organoid biobank of colorectal cancer patients
-
van de Wetering, M., Francies, H.E., Francis, J.M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161 (2015), 933–945.
-
(2015)
Cell
, vol.161
, pp. 933-945
-
-
van de Wetering, M.1
Francies, H.E.2
Francis, J.M.3
Bounova, G.4
Iorio, F.5
Pronk, A.6
van Houdt, W.7
van Gorp, J.8
Taylor-Weiner, A.9
Kester, L.10
-
33
-
-
79959761214
-
+ T cells in combination with low-dose interferon-alpha
-
+ T cells in combination with low-dose interferon-alpha. Cancer Immunol. Immunother. 60 (2011), 953–963.
-
(2011)
Cancer Immunol. Immunother.
, vol.60
, pp. 953-963
-
-
Verdegaal, E.M.1
Visser, M.2
Ramwadhdoebé, T.H.3
van der Minne, C.E.4
van Steijn, J.A.5
Kapiteijn, E.6
Haanen, J.B.7
van der Burg, S.H.8
Nortier, J.W.9
Osanto, S.10
-
34
-
-
84875490185
-
Cancer genome landscapes
-
Vogelstein, B., Papadopoulos, N., Velculescu, V.E., Zhou, S., Diaz, L.A. Jr., Kinzler, K.W., Cancer genome landscapes. Science 339 (2013), 1546–1558.
-
(2013)
Science
, vol.339
, pp. 1546-1558
-
-
Vogelstein, B.1
Papadopoulos, N.2
Velculescu, V.E.3
Zhou, S.4
Diaz, L.A.5
Kinzler, K.W.6
-
35
-
-
84945386088
-
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
-
Weeber, F., van de Wetering, M., Hoogstraat, M., Dijkstra, K.K., Krijgsman, O., Kuilman, T., Gadellaa-van Hooijdonk, C.G., van der Velden, D.L., Peeper, D.S., Cuppen, E.P., et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc. Natl. Acad. USA 112 (2015), 13308–13311.
-
(2015)
Proc. Natl. Acad. USA
, vol.112
, pp. 13308-13311
-
-
Weeber, F.1
van de Wetering, M.2
Hoogstraat, M.3
Dijkstra, K.K.4
Krijgsman, O.5
Kuilman, T.6
Gadellaa-van Hooijdonk, C.G.7
van der Velden, D.L.8
Peeper, D.S.9
Cuppen, E.P.10
-
36
-
-
84983216790
-
Mutations associated with acquired resistance to PD-1 blockade in melanoma
-
Zaretsky, J.M., Garcia-Diaz, A., Shin, D.S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D.Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N. Engl. J. Med. 375 (2016), 819–829.
-
(2016)
N. Engl. J. Med.
, vol.375
, pp. 819-829
-
-
Zaretsky, J.M.1
Garcia-Diaz, A.2
Shin, D.S.3
Escuin-Ordinas, H.4
Hugo, W.5
Hu-Lieskovan, S.6
Torrejon, D.Y.7
Abril-Rodriguez, G.8
Sandoval, S.9
Barthly, L.10
-
37
-
-
79952403534
-
Establishment and characterization of primary lung cancer cell lines from Chinese population
-
Zheng, C., Sun, Y.H., Ye, X.L., Chen, H.Q., Ji, H.B., Establishment and characterization of primary lung cancer cell lines from Chinese population. Acta Pharmacol. Sin. 32 (2011), 385–392.
-
(2011)
Acta Pharmacol. Sin.
, vol.32
, pp. 385-392
-
-
Zheng, C.1
Sun, Y.H.2
Ye, X.L.3
Chen, H.Q.4
Ji, H.B.5
|